Patents by Inventor George N. Paradissis

George N. Paradissis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6696083
    Abstract: The efficacy of vitamins and other nutritional agents in treating and preventing various disease states is improved by administering therapeutically effective levels of these agents on a substantially continuous, 24-hour basis. The concentration of lipid peroxides formed by the autoxidation of lipids, and the concentration of oxygen free radicals, are reduced by continuously administering antioxidant agents. The regeneration of nerve tissue is improved by continuously administering at least one pharmaceutically-acceptable B complex vitamin.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: February 24, 2004
    Assignee: DrugTech Corporation
    Inventors: George N. Paradissis, R. Saul Levinson, Mitchell I. Kirschner, Marc S. Hermelin
  • Publication number: 20030068372
    Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.
    Type: Application
    Filed: December 3, 2002
    Publication date: April 10, 2003
    Applicant: Drugtech Corporation
    Inventors: Mitchell I. Kirschner, R. Saul Levinson, George N. Paradissis
  • Publication number: 20020187205
    Abstract: Multi-vitamin and mineral supplements for administration to non-lactating women, which comprise specific regimens of vitamins and minerals tailored to meet the physiological needs of said women. Methods for optimizing the health of women by providing multi-vitamin and mineral supplements which are specifically tailored to achieve optimal regulation of growth, maintenance and repair of body tissue during specific stages of life with minimal side effects. Methods for formulating a multi-vitamin and mineral supplement that optimize the health of a woman and which comprise identifying life stages which correlate to specific nutritional requirements as a result of varying physiological conditions during a lifetime and selecting specific types and optimal amounts of vitamins and minerals for said life stages.
    Type: Application
    Filed: July 31, 2002
    Publication date: December 12, 2002
    Applicant: K-V Pharmaceutical Company
    Inventors: George N. Paradissis, R. Saul Levinson, Robert C. Cuca, Patrick Paul Vanek
  • Patent number: 6488956
    Abstract: Multi-vitamin and mineral supplements for administration to non-lactating women, which comprise specific regimens of vitamins and minerals tailored to meet the physiological needs of said women. Methods for optimizing the health of women by providing multi-vitamin and mineral supplements which are specifically tailored to achieve optimal regulation of growth, maintenance and repair of body tissue during specific stages of life with minimal side effects. Methods for formulating a multi-vitamin and mineral supplement that optimize the health of a woman and which comprise identifying life stages which correlate to specific nutritional requirements as a result of varying physiological conditions during a lifetime and selecting specific types and optimal amounts of vitamins and minerals for said life stages.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: December 3, 2002
    Assignee: Drugtech Corporation
    Inventors: George N. Paradissis, R. Saul Levinson, Robert C. Cuca, Patrick Paul Vanek
  • Publication number: 20020034543
    Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.
    Type: Application
    Filed: September 12, 2001
    Publication date: March 21, 2002
    Applicant: DRUGTECH CORPORATION
    Inventors: Mitchell I. Kirschner, R. Saul Levison, George N. Paradissis
  • Patent number: 6352713
    Abstract: The present inventive subject matter is directed to novel chewable prenatal nutritional supplements which contain vitamin C, as well as novel methods for providing optimal vitamin C supplementation to pregnant women. The present invention is also directed to novel compositions and methods for providing nutritional supplementation to individuals planning to conceive a child.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: March 5, 2002
    Assignee: Drugtech Corporation
    Inventors: Mitchell I. Kirschner, R. Saul Levinson, George N. Paradissis
  • Patent number: 5869084
    Abstract: Multi-vitamin and mineral supplements for administration to lactating, non-lactating, and menopausal women, which comprise specific regimens of critical nutritional agents. The supplements are specifically tailored to meet nutritional requirements and maintain a woman's health during each stage of life.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 9, 1999
    Assignee: K-V Pharmaceuticals Co.
    Inventors: George N. Paradissis, R. Saul Levinson, Gary Heeter, Robert C. Cuca, Patrick Paul Vanek
  • Patent number: 5445829
    Abstract: An extended release pharmaceutical formulation adapted to approach zero order release of drug over a 12 to at least 24 hour period, comprised of a mixture of 0 to about 50% of an immediate release particle containing a drug, inert substrate and binder, coated with talc and up to 100% of an extended release particle comprising the immediate release particle coated with a dissolution modifying system containing plasticizers and a film forming agent.
    Type: Grant
    Filed: June 15, 1992
    Date of Patent: August 29, 1995
    Assignee: KV Pharmaceutical Company
    Inventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
  • Patent number: 5296232
    Abstract: A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core composed of a pharmaceutically acceptable, film forming polymer. The film forming polymer is effective to permit release of the organic nitrate from the spheres, over a daily dosing period, at a rate that achieves a therapeutically effective level of the organic nitrate, while effecting a drug holiday towards a latter portion of the daily dosing period so as not to induce tolerance.
    Type: Grant
    Filed: May 13, 1992
    Date of Patent: March 22, 1994
    Assignee: KV Pharmaceutical Company
    Inventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
  • Patent number: 5133974
    Abstract: An extended release pharmaceutical formulation adapted to approach zero order release of drug over a 12 to at least 24 hour period, comprised of a mixture of 0 to aobut 50% of an immediate release particle containing a drug, inert substrate and binder, coated with talc and up to 100% of an extended release particle comprising the immediate release particle coated with a dissolution modifying system containing plasticizers and a film forming agent.
    Type: Grant
    Filed: January 24, 1990
    Date of Patent: July 28, 1992
    Assignee: KV Pharmaceutical Company
    Inventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
  • Patent number: 5122384
    Abstract: A controlled-release organic nitrate formulation for once-per-day oral administration is provided by spheres having a core which includes an organic nitrate, and a membrane surrounding the core composed of a pharmaceutically acceptable, film forming polymer. The film forming polymer is effective to permit release of the organic nitrate from the spheres, over a daily dosing period, at a rate that achieves a therapeutically effective level of the organic nitrate, while effecting a drug holiday towards a latter portion of the daily dosing period so as not to induce tolerance.
    Type: Grant
    Filed: May 5, 1989
    Date of Patent: June 16, 1992
    Assignee: KV Pharmaceutical Company
    Inventors: George N. Paradissis, James A. Garegnani, Roy S. Whaley
  • Patent number: 4973480
    Abstract: A tamper evident pharmaceutical capsule which contains an active agent. The capsule is coated on its external surfaces to provide an indication of tampering.
    Type: Grant
    Filed: June 23, 1989
    Date of Patent: November 27, 1990
    Assignee: K.V. Pharmaceutical Co.
    Inventors: Marc S. Hermelin, Mitchell I. Kirschner, George N. Paradissis
  • Patent number: 4844906
    Abstract: A tamper evident pharmaceutical capsule which contains an active agent. The capsule is coated on its external surfaces to provide an indication of tampering.
    Type: Grant
    Filed: March 25, 1987
    Date of Patent: July 4, 1989
    Assignee: KV Pharmaceutical Company
    Inventors: Marc S. Hermelin, Mitchell I. Kirschner, George N. Paradissis
  • Patent number: 4764375
    Abstract: A drug delivery system in which a taste masked solid is suspended in a liquid carrier. The solid has been rendered hydrophillic and its density approximates that of the carrier liquid.
    Type: Grant
    Filed: September 11, 1985
    Date of Patent: August 16, 1988
    Assignee: KV Pharmaceutical Company
    Inventor: George N. Paradissis